Thumbnail Image
Publication

Randomised phase II trial of pegylated liposomal doxorubicin (DOXILR/CAELYXR) versus doxorubicin in the treatment of advanced or metastatic sift tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group

Judson, Ian R
; 
Radford, John A
; 
Harris, Maggie A
; 
Blay, Jean-Yves
; 
Van Hoesel, Q
; 
Le Cesne, A
; 
Van Oosterom, A
; 
Clemons, Mark
; 
Kamby, C
; 
Hermans, C
... show 4 more
Citations
Altmetric:
Abstract
Authors
Judson, Ian R
Radford, John A
Harris, Maggie A
Blay, Jean-Yves
Van Hoesel, Q
Le Cesne, A
Van Oosterom, A
Clemons, Mark
Kamby, C
Hermans, C
Whittaker, J
Donato di Paola, E
Verweij, Jaap
Nielsen, S
Affiliation
Royal Marsden Hospital, London, UK
Description
Date
2001-05
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Soft Tissue Sarcoma
Doxorubicin
Liposomal Doxorubicin
Randomized Phase II Trial
Type
Article
Citation
Randomised phase II trial of pegylated liposomal doxorubicin (DOXILR/CAELYXR) versus doxorubicin in the treatment of advanced or metastatic sift tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group. 2001, 37(7) : 870-877 Eur J Cancer
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/83378
Embedded videos